Pharmaceuticals: Major
US companies operating in the same pharmaceuticals: major industry
The table below has US companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Outlook Therapeutics, Inc.. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1.11 T USD | 1,183.16 USD | +0.25% | 1.71 M | 0.55 | 40.20 | 29.43 USD | +95.14% | 0.55% | Health technology | Buy |
 JNJJohnson & Johnson | 632.29 B USD | 262.37 USD | +0.78% | 5.5 M | 0.85 | 30.41 | 8.63 USD | −7.72% | 2.01% | Health technology | Buy |
 ABBVAbbVie Inc. | 442.36 B USD | 250.33 USD | +0.35% | 4.32 M | 0.84 | 70.78 | 3.54 USD | +68.31% | 2.74% | Health technology | Buy |
 MRKMerck & Company, Inc. | 335.46 B USD | 135.97 USD | +0.10% | 8.46 M | 0.98 | 108.68 | 1.25 USD | −80.71% | 2.47% | Health technology | Buy |
 NVSNovartis AGDR | 275.5 B USD | 151.97 USD | +0.72% | 1.2 M | 0.82 | 22.93 | 6.63 USD | −4.00% | 2.04% | Health technology | Neutral |
 AZNAstraZeneca PLC | 243.32 B USD | 156.89 USD | +0.28% | 3.28 M | 0.59 | 23.75 | 6.61 USD | +17.00% | 2.14% | Health technology | Strong buy |
 NVONovo Nordisk A/SDR | 201.7 B USD | 44.88 USD | −2.20% | 14.42 M | 0.93 | 10.97 | 4.09 USD | +12.75% | 2.68% | Health technology | Buy |
 PFEPfizer, Inc. | 153.15 B USD | 26.87 USD | +0.30% | 29.18 M | 0.69 | 35.58 | 0.76 USD | −59.83% | 6.42% | Health technology | Neutral |
 BMYBristol-Myers Squibb Company | 132.02 B USD | 64.63 USD | +1.25% | 7.29 M | 0.55 | 14.24 | 4.54 USD | +83.17% | 3.93% | Health technology | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 130.67 B USD | 515.55 USD | +1.94% | 1.11 M | 0.81 | 29.99 | 17.19 USD | +22.86% | 0.00% | Health technology | Buy |
 SNYSanofiDR | 104.77 B USD | 44.41 USD | +1.58% | 1.92 M | 0.68 | 22.87 | 1.94 USD | −30.91% | 4.04% | Health technology | Buy |
 GSKGSK plcDR | 98.54 B USD | 50.28 USD | +1.53% | 2.81 M | 0.85 | 15.84 | 3.17 USD | +47.95% | 3.57% | Health technology | Neutral |
 REGNRegeneron Pharmaceuticals, Inc. | 82.97 B USD | 805.93 USD | +0.30% | 537.35 K | 0.70 | 19.92 | 40.46 USD | +1.95% | 0.45% | Health technology | Buy |
 TAKTakeda Pharmaceutical Company LimitedDR | 56.19 B USD | 17.38 USD | −1.42% | 2.46 M | 0.68 | — | −0.34 USD | −214.18% | 3.31% | Health technology | Buy |
 HLNHaleon plcDR | 42.38 B USD | 9.58 USD | −1.24% | 3.9 M | 0.56 | 19.70 | 0.49 USD | +12.39% | 1.89% | Health technology | Buy |
 ONCBeOne Medicines Ltd.DR | 40.28 B USD | 362.51 USD | +4.33% | 465.38 K | 1.00 | 63.71 | 5.69 USD | — | 0.00% | Health technology | Strong buy |
 RPRXRoyalty Pharma plc | 34.19 B USD | 59.45 USD | +1.45% | 2.28 M | 0.73 | 31.65 | 1.88 USD | −18.22% | 1.55% | Health technology | Buy |
 BIIBBiogen Inc. | 30.9 B USD | 209.15 USD | −0.32% | 617.08 K | 0.72 | 37.04 | 5.65 USD | −45.98% | 0.00% | Health technology | Buy |
 ZTSZoetis Inc. | 30.15 B USD | 72.97 USD | −1.11% | 6.36 M | 0.74 | 12.00 | 6.08 USD | +4.59% | 2.83% | Health technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 30.05 B USD | 224.60 USD | −1.77% | 1.38 M | 0.66 | 37.92 | 5.92 USD | — | 0.00% | Health technology | Buy |
 INSMInsmed Incorporated | 28.02 B USD | 128.32 USD | +3.70% | 1.9 M | 0.45 | — | −4.11 USD | +28.02% | 0.00% | Health technology | Strong buy |
 ROIVRoivant Sciences Ltd. | 26.18 B USD | 36.24 USD | +0.11% | 7.25 M | 1.17 | — | −0.44 USD | +37.24% | 0.00% | Health technology | Strong buy |
 INCYIncyte Corporation | 25.03 B USD | 123.50 USD | +2.78% | 2.02 M | 1.41 | 15.74 | 7.85 USD | +78.38% | 0.00% | Health technology | Buy |
 VTRSViatris Inc. | 18.64 B USD | 16.23 USD | 0.00% | 7.72 M | 0.61 | — | −0.36 USD | +87.72% | 2.96% | Health technology | Buy |
 JAZZJazz Pharmaceuticals plc | 16.12 B USD | 248.36 USD | +1.39% | 504.83 K | 0.52 | 17.13 | 14.50 USD | — | 0.00% | Health technology | Buy |
 ASNDAscendis Pharma A/S | 15.43 B USD | 247.40 USD | −0.44% | 554.1 K | 0.93 | 18.85 | 13.12 USD | — | 0.00% | Health technology | Strong buy |
 EXELExelixis, Inc. | 12.96 B USD | 52.32 USD | +2.11% | 2.34 M | 0.71 | 16.43 | 3.18 USD | +52.70% | 0.00% | Health technology | Buy |
 CORTCorcept Therapeutics Incorporated | 12.67 B USD | 117.17 USD | +2.36% | 540.17 K | 0.57 | 279.84 | 0.42 USD | −62.74% | 0.00% | Health technology | Buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 12.11 B USD | 524.34 USD | +3.31% | 307.34 K | 0.90 | — | −12.88 USD | −0.28% | 0.00% | Health technology | Strong buy |
 CYTKCytokinetics, Incorporated | 10.55 B USD | 75.87 USD | +2.35% | 1.49 M | 0.69 | — | −7.22 USD | −41.03% | 0.00% | Health technology | Strong buy |
 PRAXPraxis Precision Medicines, Inc. | 10.51 B USD | 376.38 USD | +2.61% | 542.65 K | 1.12 | — | −12.94 USD | −5.32% | 0.00% | Health technology | Strong buy |
 RDYDr. Reddy's Laboratories LtdDR | 10.5 B USD | 12.11 USD | −1.30% | 2.04 M | 0.80 | 27.21 | 0.45 USD | −44.32% | 0.52% | Health technology | Neutral |
 PTGXProtagonist Therapeutics, Inc. | 10.26 B USD | 158.62 USD | +2.27% | 431.93 K | 0.90 | 152.95 | 1.04 USD | +45.54% | 0.00% | Health technology | Strong buy |
 IONSIonis Pharmaceuticals, Inc. | 9.74 B USD | 58.63 USD | +2.43% | 1.98 M | 0.90 | — | −3.47 USD | −87.55% | 0.00% | Health technology | Buy |
 RGENRepligen Corporation | 9.54 B USD | 169.04 USD | +1.32% | 655.19 K | 0.68 | 230.39 | 0.73 USD | — | 0.00% | Health technology | Strong buy |
 SYRESpyre Therapeutics, Inc. | 9.22 B USD | 104.60 USD | +0.94% | 882.12 K | 1.18 | — | −2.18 USD | +28.51% | 0.00% | Health technology | Strong buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 8.99 B USD | 84.75 USD | +0.06% | 1.64 M | 0.77 | — | −5.05 USD | −22.68% | 0.00% | Health technology | Neutral |
 IBRXImmunityBio, Inc. | 8.39 B USD | 7.92 USD | +4.62% | 6.79 M | 0.81 | — | −0.97 USD | −96.55% | 0.00% | Health technology | Strong buy |
 ALKSAlkermes plc | 8.36 B USD | 49.85 USD | +1.61% | 763.82 K | 0.52 | 129.48 | 0.39 USD | −81.52% | 0.00% | Health technology | Buy |
 RYTMRhythm Pharmaceuticals, Inc. | 7.95 B USD | 115.44 USD | −0.03% | 412.04 K | 0.49 | — | −3.12 USD | −3.31% | 0.00% | Health technology | Strong buy |
 TGTXTG Therapeutics, Inc. | 7.54 B USD | 49.28 USD | +1.11% | 1.02 M | 0.41 | 17.95 | 2.75 USD | +633.70% | 0.00% | Health technology | Strong buy |
 ORKAOruka Therapeutics, Inc. | 7.46 B USD | 112.66 USD | +1.46% | 514.8 K | 0.69 | — | −2.46 USD | +32.27% | 0.00% | Health technology | Strong buy |
 LQDALiquidia Corporation | 6.95 B USD | 77.70 USD | +4.38% | 1.52 M | 0.81 | 56.95 | 1.36 USD | — | 0.00% | Health technology | Buy |
 BDRXBiodexa Pharmaceuticals plcDR | 6.86 B USD | 1.42 USD | −6.58% | 32.71 K | 0.26 | — | −103.95 USD | +88.07% | 0.00% | Health technology | No rating |
 GRFSGrifols, S.A.DR | 6.84 B USD | 7.77 USD | −0.13% | 295.96 K | 0.82 | 10.03 | 0.77 USD | +61.67% | 2.93% | Health technology | Neutral |
 BLTEBelite Bio, IncDR | 6.56 B USD | 163.21 USD | +0.25% | 177.5 K | 0.92 | — | −2.73 USD | −76.46% | 0.00% | Health technology | Strong buy |
 MIRMMirum Pharmaceuticals, Inc. | 6.48 B USD | 99.83 USD | −0.80% | 407.63 K | 0.45 | — | −14.55 USD | −1,101.55% | 0.00% | Health technology | Strong buy |
 ERASErasca, Inc. | 6.39 B USD | 18.28 USD | −0.54% | 2.22 M | 0.71 | — | −0.95 USD | −110.63% | 0.00% | Health technology | Strong buy |
 KNSAKiniksa Pharmaceuticals International, plc | 6.18 B USD | 79.18 USD | +3.17% | 320.53 K | 0.70 | 80.51 | 0.98 USD | +2,292.94% | 0.00% | Health technology | Strong buy |
 PTCTPTC Therapeutics, Inc. | 6.08 B USD | 72.88 USD | +1.65% | 985.71 K | 1.03 | — | −0.59 USD | −108.51% | 0.00% | Health technology | Buy |
 DFTXDefinium Therapeutics, Inc. | 6.08 B USD | 45.26 USD | +6.17% | 2.27 M | 0.83 | — | −3.44 USD | −134.91% | 0.00% | Health technology | Strong buy |
 XENEXenon Pharmaceuticals Inc. | 6.04 B USD | 62.36 USD | +0.02% | 687.46 K | 1.09 | — | −4.74 USD | −33.88% | 0.00% | Health technology | Strong buy |
 TVTXTravere Therapeutics, Inc. | 5.99 B USD | 63.53 USD | +2.24% | 1.57 M | 0.73 | — | −0.76 USD | +62.56% | 0.00% | Health technology | Strong buy |
 AMRXAmneal Pharmaceuticals, Inc. | 5.88 B USD | 18.42 USD | +1.49% | 1.62 M | 0.82 | 38.44 | 0.48 USD | +7,387.50% | 0.00% | Health technology | Strong buy |
 LGNDLigand Pharmaceuticals Incorporated | 5.82 B USD | 291.77 USD | −0.96% | 145.58 K | 0.52 | 31.19 | 9.35 USD | — | 0.00% | Health technology | Strong buy |
 ACADACADIA Pharmaceuticals Inc. | 5 B USD | 29.01 USD | +2.73% | 1.12 M | 0.53 | 13.07 | 2.22 USD | +66.85% | 0.00% | Health technology | Buy |
 INDVIndivior Pharmaceuticals, Inc. | 4.61 B USD | 39.08 USD | +0.18% | 2.02 M | 0.62 | 13.88 | 2.82 USD | +297.21% | 0.00% | Health technology | Strong buy |
 MANEVeradermics, Incorporated | 4.52 B USD | 108.22 USD | −3.98% | 581.07 K | 0.58 | — | — | — | 0.00% | Health technology | Strong buy |
| PPBLSParabilis Medicines, Inc. | 4.4 B USD | 37.22 USD | +0.40% | 385.26 K | 1.14 | — | — | — | 0.00% | Health technology | Strong buy |
 LEGNLegend Biotech CorporationDR | 3.95 B USD | 20.65 USD | +1.37% | 1.27 M | 0.50 | — | −0.51 USD | +71.61% | 0.00% | Health technology | Buy |
 VKTXViking Therapeutics, Inc. | 3.92 B USD | 33.63 USD | +1.33% | 1.52 M | 0.90 | — | −4.66 USD | −203.77% | 0.00% | Health technology | Strong buy |
 GPCRStructure Therapeutics Inc.DR | 3.89 B USD | 53.76 USD | −1.38% | 304.98 K | 0.52 | — | −3.08 USD | +1.47% | 0.00% | Health technology | Strong buy |
 OGNOrganon & Co. | 3.6 B USD | 13.70 USD | −0.15% | 1.99 M | 0.80 | 17.55 | 0.78 USD | −71.01% | 0.58% | Health technology | Neutral |
 IDYAIDEAYA Biosciences, Inc. | 3.53 B USD | 36.54 USD | +0.66% | 427.74 K | 0.67 | — | −1.94 USD | +48.68% | 0.00% | Health technology | Strong buy |
 ALMSAlumis Inc. | 3.25 B USD | 25.50 USD | +0.75% | 732.7 K | 0.81 | — | −3.81 USD | +15.39% | 0.00% | Health technology | Strong buy |
 ARQTArcutis Biotherapeutics, Inc. | 3.22 B USD | 25.61 USD | −2.21% | 1.63 M | 0.87 | 123.66 | 0.21 USD | — | 0.00% | Health technology | Strong buy |
 NAMSNewAmsterdam Pharma Company N.V. | 3.22 B USD | 26.90 USD | −0.30% | 834.95 K | 0.64 | — | −2.18 USD | −35.06% | 0.00% | Health technology | Strong buy |
 TARSTarsus Pharmaceuticals, Inc. | 3.1 B USD | 70.61 USD | +2.04% | 541.17 K | 0.66 | — | −1.08 USD | +53.58% | 0.00% | Health technology | Strong buy |
 SUPNSupernus Pharmaceuticals, Inc. | 2.81 B USD | 48.27 USD | 0.00% | 528.6 K | 0.35 | — | −1.91 USD | −267.30% | 0.00% | Health technology | Buy |
 ATAIAtaiBeckley Inc. | 2.69 B USD | 7.24 USD | −0.28% | 7.6 M | 1.21 | — | −2.19 USD | −513.49% | 0.00% | Health technology | Neutral |
 RGCRegencell Bioscience Holdings Limited | 2.65 B USD | 5.35 USD | −1.83% | 184.08 K | 0.87 | — | −0.01 USD | −71.08% | 0.00% | Health technology | No rating |
 SLSSELLAS Life Sciences Group, Inc. | 2.63 B USD | 13.00 USD | +1.72% | 5.4 M | 0.99 | — | −0.21 USD | +35.38% | 0.00% | Health technology | Strong buy |
 VRDNViridian Therapeutics, Inc. | 2.62 B USD | 23.09 USD | +4.57% | 1.89 M | 0.88 | — | −3.71 USD | +13.06% | 0.00% | Health technology | Strong buy |
 RAREUltragenyx Pharmaceutical Inc. | 2.58 B USD | 26.13 USD | −1.36% | 1.31 M | 0.63 | — | −5.84 USD | −5.66% | 0.00% | Health technology | Strong buy |
 NKTRNektar Therapeutics | 2.46 B USD | 72.67 USD | −0.48% | 681.8 K | 1.13 | — | −6.70 USD | +23.18% | 0.00% | Health technology | Strong buy |
 AMLXAmylyx Pharmaceuticals, Inc. | 2.39 B USD | 21.43 USD | −0.92% | 1.01 M | 0.53 | — | −1.43 USD | +42.67% | 0.00% | Health technology | Strong buy |
 PBHPrestige Consumer Healthcare Inc. | 2.37 B USD | 50.04 USD | −2.61% | 576.41 K | 0.84 | 14.01 | 3.57 USD | −16.20% | 0.00% | Health technology | Buy |
 OCULOcular Therapeutix, Inc. | 2.34 B USD | 10.65 USD | +6.08% | 11.14 M | 4.91 | — | −1.41 USD | −10.60% | 0.00% | Health technology | Strong buy |
 VCELVericel Corporation | 2.23 B USD | 43.59 USD | −1.38% | 263.14 K | 0.64 | 94.31 | 0.46 USD | +270.65% | 0.00% | Health technology | Strong buy |
 HRMYHarmony Biosciences Holdings, Inc. | 2.22 B USD | 38.14 USD | +0.05% | 734.28 K | 0.84 | 12.36 | 3.09 USD | −0.53% | 0.00% | Health technology | Buy |
 BHVNBiohaven Ltd. | 2.18 B USD | 14.46 USD | −1.23% | 1.85 M | 1.07 | — | −4.65 USD | +39.33% | 0.00% | Health technology | Buy |
 HCMHUTCHMED (China) LimitedDR | 2.13 B USD | 12.56 USD | +2.95% | 89.21 K | 2.37 | 123.50 | 0.10 USD | −96.21% | 0.00% | Health technology | Buy |
| BBRVEBraveheart Bio, Inc. | 2.11 B USD | 27.66 USD | +2.33% | 310.16 K | — | — | — | — | 0.00% | Health technology | No rating |
 GHRSGH Research PLC | 2.06 B USD | 29.98 USD | +1.66% | 182.23 K | 0.40 | — | −0.99 USD | −33.76% | 0.00% | Health technology | Strong buy |
 AGIOAgios Pharmaceuticals, Inc. | 2.01 B USD | 33.63 USD | +0.21% | 969.24 K | 0.88 | — | −7.01 USD | −163.46% | 0.00% | Health technology | Buy |
 SRPTSarepta Therapeutics, Inc. | 1.92 B USD | 18.18 USD | +0.44% | 1.67 M | 0.55 | — | −2.90 USD | −281.95% | 0.00% | Health technology | Neutral |
| DDMRADamora Therapeutics, Inc. | 1.92 B USD | 31.09 USD | +0.16% | 362.71 K | 1.03 | — | −124.78 USD | −850.33% | 0.00% | Health technology | Strong buy |
 NBTXNanobiotix S.A.DR | 1.89 B USD | 42.05 USD | +9.76% | 522.34 K | 3.86 | — | −0.57 USD | +50.79% | 0.00% | Health technology | Strong buy |
 ZYMEZymeworks Inc. | 1.81 B USD | 25.31 USD | +0.76% | 442.35 K | 0.82 | — | −2.01 USD | −105.50% | 0.00% | Health technology | Strong buy |
 PRGOPerrigo Company plc | 1.78 B USD | 12.82 USD | −1.69% | 2.14 M | 0.67 | — | −12.51 USD | −2,139.20% | 8.90% | Health technology | Buy |
 ETONEton Pharmaceuticals, Inc. | 1.76 B USD | 61.73 USD | +4.88% | 1.25 M | 1.95 | 163.22 | 0.38 USD | — | 0.00% | Health technology | Strong buy |
 AAPGAscentage Pharma Group International - American Depository SharesDR | 1.7 B USD | 18.20 USD | −4.21% | 5.87 K | 1.10 | — | −1.94 USD | −157.55% | 0.00% | Health technology | Strong buy |
 AVLNAvalyn Pharma Inc. | 1.7 B USD | 38.25 USD | −2.55% | 148.86 K | 0.77 | — | — | — | 0.00% | Health technology | Strong buy |
 BCAXBicara Therapeutics Inc. | 1.65 B USD | 24.94 USD | +2.72% | 434.47 K | 0.54 | — | −3.09 USD | −63.70% | 0.00% | Health technology | Strong buy |
 MAZEMaze Therapeutics, Inc. | 1.55 B USD | 27.95 USD | +2.83% | 322.04 K | 0.86 | — | −2.53 USD | −50.45% | 0.00% | Health technology | Strong buy |
 INVAInnoviva, Inc. | 1.51 B USD | 20.96 USD | −1.09% | 617.96 K | 0.82 | 5.11 | 4.10 USD | +1,137.16% | 0.00% | Health technology | Buy |
 LBRXLB Pharmaceuticals Inc | 1.49 B USD | 46.23 USD | −3.23% | 261.75 K | 0.62 | — | −2.98 USD | −132.05% | 0.00% | Health technology | Strong buy |
 HROWHarrow, Inc. | 1.48 B USD | 39.48 USD | −1.39% | 322.91 K | 0.51 | — | −1.00 USD | −236.87% | 0.00% | Health technology | Strong buy |
 PAHCPhibro Animal Health Corporation | 1.4 B USD | 34.63 USD | +0.79% | 152.62 K | 0.89 | 14.88 | 2.33 USD | +197.89% | 1.40% | Health technology | Neutral |
 MLTXMoonLake Immunotherapeutics | 1.39 B USD | 16.35 USD | −0.73% | 1.2 M | 0.73 | — | −3.84 USD | −37.48% | 0.00% | Health technology | Buy |